MiRNA Signatures Show Promising Potential as Biomarkers for Broad Range of Diseases
The latest study results that illustrate the high potential of microRNAs (miRNAs) as biomarkers for a broad range of dis…
The latest study results that illustrate the high potential of microRNAs (miRNAs) as biomarkers for a broad range of dis…
Im Rahmen der vom 12.-15. Juni 2010 in Göteborg (Schweden) stattfindenden "42nd European Human Genetics Conference" (ESH…
febit today announced that the company now offers whole genome sequencing services in Europe for a broad range of specie…
Ab sofort bietet die febit biomed gmbh einen Sequenzierservice für komplette Genome verschiedenster Spezies an. febit bi…
febit today announced that an updated version of the company's Geniom Biochip containing 58 new discovered sequences in…
58 neue microRNA (miRNA) Sequenzen konnten im Rahmen einer Studie identifiziert werden, die mit dem Applied Biosystems S…
febit today announced the launch of its HybSelector, a new instrument for high throughput targeted resequencing, at the…
febit stellt in der kommenden Woche auf der 11. Konferenz "Advances in Genome Biology and Technology" (AGBT) in Florida…
The Molecular Genetics Core Facility (MGCF) at Children's Hospital Boston chose febit's HybSelect technology which will…
Die Molecular Genetics Core Facility (MGCF) am Children's Hospital Boston (USA) hat sich für den Einsatz von febit's Hyb…